Faktor Risiko pada Peningkatan Kasus Multidrug-Resistant Tuberculosis (MDR-TB) di Indonesia: Tinjauan Literatur

Benny Chandra; Riza Fikriana; Wiwit Dwi Nurbadriyah

doi:10.30651/jkm.v10i1.25482

Authors

Benny Chandra Universitas Kepanjen
Riza Fikriana
Wiwit Dwi Nurbadriyah

DOI:

https://doi.org/10.30651/jkm.v10i1.25482

Keywords:

risk factors, Indonesia, multidrug-resistant, tuberculosis

Abstract

Objective: to analyze the risk factors that affect MDR-TB in Indonesia through a literature review.

Methods: This study employed a literature review method to analyze the risk factors contributing to the increase in multidrug-resistant tuberculosis (MDR-TB) cases in Indonesia. Relevant articles published between 2020 and 2024 were selected through databases such as Google Scholar, Garuda Kemdikbud, and ResearchGate, with the final analysis focusing on 9 articles that met the inclusion criteria.

Results: The results of the study showed that the incidence of MDR-TB was influenced by internal factors such as TB treatment history, drug availability, nutritional status, comorbidities (diabetes, HIV/AIDS), drug side effects, and smoking. External factors include housing density, social support, socioeconomic conditions, access to health facilities, the role of PMOs, history of contact with MDR-TB patients, and jobs that increase risk.

Conclusion: The practical implications are the importance of improving the implementation of treatment through DOT and technology programs, patient education, and management of risk factors such as smoking, malnutrition, and comorbidities. Improving access to health, social support, and healthier environmental conditions can also prevent the spread and improve the success of MDR-TB treatment.

References

Admassu, F. et al. (2023) ‘Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study’, BMJ open, 13(1), p. e061836.

Arianti, A.R. et al. (2024) ‘Risk Factor Analysis of Drug-Resistant Tuberculosis in Tuberculosis Patients at Level II Health Facilities in Depok City’, Daengku: Journal of Humanities and Social Sciences Innovation, 4(1), pp. 6–13.

Dheda, K. et al. (2024) ‘Multidrug-resistant tuberculosis’, Nature Reviews Disease Primers, 10(1), p. 22.

Febriyanti, R.W. et al. (2021) ‘Tuberkulosis Paru dengan Risiko Multi Drug Resistant di RS Rujukan Tertier di Jawa Tengah’, Herb-Medicine Journal [Preprint].

Feldman, C. et al. (2024) ‘Cigarette Smoking as a Risk Factor for Tuberculosis in Adults: Epidemiology and Aspects of Disease Pathogenesis’, Pathogens, 13(2), p. 151.

Gao, W. et al. (2024) ‘Drug-resistance characteristics, genetic diversity, and transmission dynamics of multidrug-resistant or rifampicin-resistant Mycobacterium tuberculosis from 2019 to 2021 in Sichuan, China’, Antimicrobial Resistance & Infection Control, 13(1), p. 125.

Groenweghe, E. (2023) ‘Outbreak of Multidrug-Resistant Tuberculosis—Kansas, 2021–2022’, MMWR. Morbidity and Mortality Weekly Report, 72.

Imam, F.R.S., Umboh, J.M.L. and Tuda, J.S.B. (2023) ‘Faktor-faktor Risiko yang Berhubungan dengan Kejadian Multidrug-Resistant Tuberculosis (TB-MDR) di Kota Ternate, Maluku Utara’, e-CliniC, 11(3), pp. 260–268.

Iskandar, T. et al. (2022) ‘Pengaruh Faktor Lingkungan terhadap Kejadian Multidrug-Resistant (MDR) di Kabupaten Jember’, CoMPHI Journal: Community Medicine and Public Health of Indonesia Journal, 3(2), pp. 46–52.

Kementerian Kesehatan RI (2022) Laporan Program Penanggulangan Tuberkulosis Tahun 2022. Jakarta. Available at: https://www.tbindonesia.or.id/wp-content/uploads/2023/09/Laporan-Tahunan-Program-TBC-2022.pdf.

Kilima, S.P. et al. (2024) ‘Perceived access to social support during and after TB treatment in Mbeya and Songwe regions, Tanzania: perspectives from TB patients and survivors set against health care providers’, Frontiers in Health Services, 4, p. 1273739.

Li, A. et al. (2023) ‘Prevalence and risk factors of malnutrition in patients with pulmonary tuberculosis: A systematic review and meta-analysis’, Frontiers in Medicine, 10, p. 1173619.

Magassouba, A.S. et al. (2021) ‘Malnutrition prevalence and associated biochemical factors among drug-resistance tuberculosis (DR-TB) patients at key treatment sites in Conakry City, Republic of Guinea’, Pan African Medical Journal, 38(1).

Mashidayanti, A., Nurlely, N. and Kartinah, N. (2020) ‘Faktor Risiko Yang Berpengaruh Pada Kejadian Tuberkulosis dengan Multidrug-Resistant Tuberculosis (MDR-TB) di RSUD Ulin Banjarmasin’, Jurnal Pharmascience, 7, p. 139. Available at: https://doi.org/10.20527/jps.v7i2.7928.

McNabb, K.C. et al. (2024) ‘Travel distance to rifampicin-resistant tuberculosis treatment and its impact on loss to follow-up: the importance of continued RR-TB treatment decentralization in South Africa’, BMC public health, 24(1), p. 578.

Miftah, G., Khasanah, N. and Alberta, L.T. (2024) ‘Perilaku Kepatuhan Minum Obat Pasien Tuberculosis Paru Berbasis Theory Of Planned Behavior (TPB) Di Puskesmas Banyu Urip Kota Surabaya: Pulmonary TB, compliance behavior and taking medication’, Jurnal Keperawatan, 18(2), pp. 100–110.

Migliori, G.B. et al. (2020) ‘MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network’, International Journal of Infectious Diseases, 92, pp. S15–S25. Available at: https://doi.org/10.1016/j.ijid.2020.01.042.

Musie, A. and Wolvaardt, J.E. (2021) ‘Risk and reward: Experiences of healthcare professionals caring for drug-resistant tuberculosis patients’, SA Journal of Human Resource Management, 19, p. 1191.

Ratnasari, N.Y. (2020) ‘Faktor Resiko Kejadian Multi Drug Resistant Tuberculosis (MDR TB) di Surakarta, Jawa Tengah’, Jurnal Penelitian Kesehatan" SUARA FORIKES"(Journal of Health Research" Forikes Voice"), 11, pp. 67–72.

Saputra, H.L., Yulendasari, R. and Kusumaningsih, D. (2022) ‘Faktor-faktor yang berhubungan dengan Multidrug Resistant Tuberculosis (MDR-TB) pada pasien tuberkulosis paru’, Holistik Jurnal Kesehatan, 16(6), pp. 516–528.

Shah, A.D. (2024) ‘Treatment Adherence among MDR TB Patients in Nepal’, Texila International Journal Of Public Health [Preprint]. Available at: https://www.texilajournal.com/public-health/article/1596-family-and-social.

Song, H.-W. et al. (2024) ‘Tracking multidrug resistant tuberculosis: a 30-year analysis of global, regional, and national trends’, Frontiers in Public Health, 12, p. 1408316.

Sutrisna, M. and Rahmadani, E. (2022) ‘Hubungan Usia dan Jenis Kelamin dengan TB MDR’, Sehat Rakyat: Jurnal Kesehatan Masyarakat, 1(4), pp. 370–376.

Wahyuningsih, S. et al. (2023) ‘An analysis of risk factors for Multidrug Resistant Tuberculosis (MDR-TB): a hospital-based study’, Journal of Public Health and Development, 21(2), pp. 91–101.

World Health Organization (2020) Addressing TB comorbidities and health-related risk factors, World Health Organization. Available at: https://www.who.int/activities/addressing-tb-comorbidities-and-health-related-risk-factors (Accessed: 13 December 2024).

World Health Organization (2024a) Global tuberculosis report 2024, World Health Organization. Available at: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2024 (Accessed: 13 December 2024).

World Health Organization (2024b) WHO guidance on TB surveillance (2024) an overview, World Health Organization. Available at: https://cdn.who.int/media/docs/default-source/hq-tuberculosis/publications-2023/tb-surveillance-guidance-summary-slides.pdf?sfvrsn=74b45b0f_3 (Accessed: 13 December 2024).

Wu, L., Cai, X. and Jiang, X. (2024) ‘Risk factors for multidrug-resistant tuberculosis: a predictive model study’, Frontiers in Medicine, 11, p. 1410690.

Xi, Y. et al. (2022) ‘Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis’, PloS one, 17(6), p. e0270003.